Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 64.00 | |
5 mg | In stock | $ 155.00 | |
10 mg | In stock | $ 195.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | Inquiry | |
1 mL * 10 mM (in DMSO) | In stock | $ 208.00 |
Description | JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity. |
Targets&IC50 | ERK5:88 nM |
In vitro | JWG-071 demonstrates IC50 values of 88 nM and 109 nM for inhibiting ERK5 and LRRK2, respectively.[1] |
Synonyms | JWG071, JWG 071 |
Molecular Weight | 612.77 |
Formula | C34H44N8O3 |
CAS No. | 2250323-50-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 61.28 mg/mL (100 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JWG-071 2250323-50-1 Chromatin/Epigenetic MAPK Epigenetic Reader Domain ERK JWG071 JWG 071 inhibitor inhibit